Informatics

The goal of health informatics systems is to enable smooth transfer of data and cybersecurity across the healthcare enterprise. This includes patient information, images, subspecialty reporting systems, lab results, scheduling, revenue management, hospital inventory, and many other health IT systems. These systems include the electronic medical record (EMR) admission discharge and transfer (ADT) system, hospital information system (HIS), radiology picture archiving and communication systems (PACS), cardiovascular information systems (CVIS), archive solutions including cloud storage and vendor neutral archives (VNA), and other medical informatics systems.

ONC awards AHIMA $1.2M grant for HIE project

The Office of the National Coordinator for Health IT (ONC) has awarded the American Health Information Management Association (AHIMA) Foundation a one-year, $1.2 million grant to continue the state-level health information exchange (SL-HIE) consensus project to assist states with nationwide HIE adoption, planning and implementation.

NASCIO: State CIOs should be key stakeholders in HIE development

State CIOs and IT executives should establish themselves as key stakeholders in the development of state health information exchanges (HIE), according to a report issued by the National Association of State Chief Information Officers (NASCIO).

iSoft enters U.S. market with $15M BridgeForward purchase

Health IT software developer iSoft Group has acquired application integration software developer BridgeForward, in a deal worth up to $14.9 million. The acquisition boosts iSofts portfolio of interoperable solutions for the healthcare market, and gives the Sydney, Australia-based company its first toehold in the United States.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.